| Literature DB >> 33814500 |
Chika Yamada1, Yoshimitsu Shimomura1, Kimimori Kamijyo1, Madoka Kanda-Kato1, Satoshi Yoshioka1, Daisuke Yamashita2, Takayuki Ishikawa1.
Abstract
We herein report a rare case of BCR-ABL1-positive B-lymphoblastic lymphoma (B-LBL). An 18-year-old woman had a history of persistent left-sided chest pain. Positron emission tomography showed increased metabolic activity in the fifth rib, duodenum, and pancreas. The pathological findings of the pancreas, duodenum, and bone marrow confirmed the diagnosis of B-LBL. Polymerase chain reaction of duodenum and bone marrow also revealed a minor BCR-ABL1 fusion gene. She was diagnosed with BCR-ABL1-positive B-LBL and administered dasatinib and prednisolone. She achieved complete remission two weeks after the initiation of the treatment. She received stem cell transplantation after consolidation chemotherapy and sustained complete remission.Entities:
Keywords: :BCR-ABL1; B-lymphoblastic lymphoma; and dasatinib; tyrosine kinase inhibitors
Year: 2021 PMID: 33814500 DOI: 10.2169/internalmedicine.7066-21
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271